X

Trial Profile

LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Mar 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sonidegib (Primary) ; Paclitaxel
Indications Anal cancer; Breast cancer; Cholangiocarcinoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours; Uterine cancer
Focus Adverse reactions

Most Recent Events

20 Mar 2017 Results assessing safety and efficacy of sonidegib in combination with paclitaxel, published in the Investigational New Drugs
23 Nov 2016 Status changed from active, no longer recruiting to completed.
28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com